NOVO-CHOLAMINE - PWR 4G/DOSE 4 G
CHOLESTYRAMINE RESIN : 4 G · DIN 02139189 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-CHOLAMINE - PWR 4G/DOSE?
NOVO-CHOLAMINE - PWR 4G/DOSE 4 G contains CHOLESTYRAMINE RESIN : 4 G. It is listed in the Health Canada Drug Product Database under DIN 02139189, held by NOVOPHARM LIMITED, supplied as POWDER ; SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02139189 |
|---|---|
| Brand name | NOVO-CHOLAMINE - PWR 4G/DOSE |
| Generic / active ingredient | CHOLESTYRAMINE RESIN : 4 G |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 4 G |
| Dosage form | POWDER ; SUSPENSION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AC01 COLESTYRAMINE |
| AHFS class | 24:06.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C10AC01 COLESTYRAMINE. 3 of 23 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CHOLESTYRAMINE-ODAN | 4 G | Powder | ODAN LABORATORIES LTD | MARKETED | DIN 02455609 |
| JAMP-CHOLESTYRAMINE | 4 G | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | MARKETED | DIN 02478595 |
| OLESTYR | 4 G | POWDER FOR SUSPENSION | PHARMASCIENCE INC | MARKETED | DIN 02210320 |
| ALTI-CHOLESTYRAMINE LIGHT | 4 G | POWDER ; PACKAGE | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02054825 |
| CHOLESTYRAMINE | 4 G / 5 G | POWDER FOR SUSPENSION | SORRES PHARMA INC | CANCELLED POST MARKET | DIN 02236969 |
| CHOLESTYRAMINE | 4 G / 9 G | POWDER FOR SUSPENSION | SORRES PHARMA INC | CANCELLED POST MARKET | DIN 02236970 |
| JAMP-CHOLESTYRAMINE | 4 G | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | APPROVED | DIN 02494531 |
| NOVO-CHOLAMINE LIGHT - PWR 4G/DOSE | 4 G | SUSPENSION ; POWDER | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02139197 |
| OLESTYR | 4 G | POWDER FOR SUSPENSION | PHARMASCIENCE INC | DORMANT | DIN 00890960 |
| PHL-CHOLESTYRAMINE LIGHT - 210G TIN | 4 G / 5 G | POWDER FOR SUSPENSION | PHARMEL INC | CANCELLED POST MARKET | DIN 02237132 |
Who else supplies COLESTYRAMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COLESTYRAMINE appears in 17 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.